ORGANOGENESIS
Lobbying client. Federal LDA filings.
- Source id
73171- General description
- Regenerative medicine
- State
- MA
- Country
- US
- Principal place of business
- US
- Effective date
- 2026-05-15
- Total spend (across 1 ingested filings)
- $0
Filings (1) — $0
| Posted | Type | Year | Lobbying firm | Income |
|---|---|---|---|---|
| 2026-05-18 | RR | 2026 | DONOVAN STRATEGIES LLC | — |
Connected on the graph
10 typed relationships in the influence graph — 7 inbound, 3 outbound, grouped by type.
lobbied for (6)
| date | dir | entity | amount | role | source |
|---|---|---|---|---|---|
| — | ← | Joseph Donovan | — | lda_lobbyist_client | |
| — | ← | Dan Renberg | — | lda_lobbyist_client | |
| — | ← | Elizabeth Horner | — | lda_lobbyist_client | |
| — | ← | Oliver Spurgeon Iii | — | lda_lobbyist_client | |
| — | ← | Blake Thelander | — | lda_lobbyist_client | |
| — | ← | Kelsey Griswold-Berger | — | lda_lobbyist_client |
lobbies on bill (3)
| date | dir | entity | amount | role | source |
|---|---|---|---|---|---|
| 2026-01-01 | → | Skin Substitute Access and Payment Reform Act of 2025 S 2561 · introduced 2025-07-31 · latest action: Read twice and referred to the Committee on Finance. | — | S. 2561 | lobbying_bill_mention |
| 2026-01-01 | → | Advanced Wound Care and Regenerative Medicine Access and Reform Act HR 6852 · introduced 2025-12-18 · latest action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determ… | — | H.R.6852 | lobbying_bill_mention |
| 2026-01-01 | → | Skin Substitute Access and Payment Reform Act HR 5768 · introduced 2025-10-17 · latest action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determ… | — | H.R. 5768 | lobbying_bill_mention |
lobbies for (1)
| date | dir | entity | amount | role | source |
|---|---|---|---|---|---|
| 2026-01-01 | ← | ARENTFOX SCHIFF LLP | $20,000 | lda_filing |